Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008698:Mesylates / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008698:Mesylates; C001441:improsan